Literature DB >> 12745546

Upregulation of expression of the chemokine receptor CCR5 by hydrogen peroxide in human monocytes.

Geneviève Lehoux1, Christian Le Gouill, Jana Stankova, Marek Rola-Pleszczynski.   

Abstract

The objective of this study was to test the hypothesis that an oxidative stress can serve as a signal to regulate the expression of CCR5. When human monocytes were exposed to graded concentration of hydrogen peroxide (H(2)O(2)), CCR5 mRNA levels increased maximally at 4 h of exposure to 200 microM of H(2)O(2) and decreased by 24 h of treatment. Pretreatment of monocytes with the NF-kappaB inhibitor BAY 11-8072 blocked the H(2)O(2)-induced augmentation of CCR5 mRNA expression, suggesting a role for this transcription factor in the regulation of CCR5 expression. CCR5 protein expression on the plasma membrane was also increased by treatment with H(2)O(2,) as assessed by flow cytometry. This was accompanied by enhanced responsiveness of H(2)O(2)-pretreated monocytes to the CCR5 ligand MIP-1beta in terms of chemotaxis and c-fos gene activation. Our results suggest that oxidative stress may indeed modulate the expression of chemokine receptors and thus contribute to regulation of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745546      PMCID: PMC1781589          DOI: 10.1080/0962935031000096962

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  53 in total

Review 1.  Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review).

Authors:  R Schreck; K Albermann; P A Baeuerle
Journal:  Free Radic Res Commun       Date:  1992

Review 2.  Redox control of transcription: sensors, response regulators, activators and repressors.

Authors:  J F Allen
Journal:  FEBS Lett       Date:  1993-10-18       Impact factor: 4.124

3.  Myeloperoxidase deficiency in a patient with rheumatoid arthritis: oxygenation and radical activity by phagocytic cells.

Authors:  A L Bell; G M Markey; H D Alexander; T C Morris; S A McMillan; J A McNally
Journal:  Br J Rheumatol       Date:  1993-02

Review 4.  Oxidative stress as a mediator of apoptosis.

Authors:  T M Buttke; P A Sandstrom
Journal:  Immunol Today       Date:  1994-01

5.  Regulation of the transcription factors NF-kappa B and AP-1 by redox changes.

Authors:  M Meyer; H L Pahl; P A Baeuerle
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

6.  Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase.

Authors:  J A Satriano; M Shuldiner; K Hora; Y Xing; Z Shan; D Schlondorff
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract.

Authors:  Z Xing; M Jordana; T Braciak; T Ohtoshi; J Gauldie
Journal:  Am J Respir Cell Mol Biol       Date:  1993-09       Impact factor: 6.914

8.  Increased oxygen species generation in blood monocytes of asthmatic patients.

Authors:  I Vachier; M Damon; C Le Doucen; A C de Paulet; P Chanez; F B Michel; P Godard
Journal:  Am Rev Respir Dis       Date:  1992-11

9.  Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection.

Authors:  J C Bandres; J Trial; D M Musher; R D Rossen
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

10.  H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

Authors:  M Meyer; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  6 in total

Review 1.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

2.  People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells.

Authors:  Louise E van Eekeren; Vasiliki Matzaraki; Zhenhua Zhang; Lisa van de Wijer; Marc J T Blaauw; Marien I de Jonge; Linos Vandekerckhove; Wim Trypsteen; Leo A B Joosten; Mihai G Netea; Quirijn de Mast; Hans J P M Koenen; Yang Li; André J A M van der Ven
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

3.  Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients.

Authors:  Juliana Laino do Val Carneiro; Suzana Lucy Nixdorf; Mário Sérgio Mantovani; Ana Cristina da Silva do Amaral Herrera; Mateus Nobrega Aoki; Marla Karine Amarante; Bruno Alberto Fabris; Maria Helena Pelegrinelli Fungaro; Maria Angelica Ehara Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

4.  COPD monocytes demonstrate impaired migratory ability.

Authors:  Arjun K Ravi; Jonathan Plumb; Rosemary Gaskell; Sarah Mason; Caroline S Broome; George Booth; Matthew Catley; Jørgen Vestbo; Dave Singh
Journal:  Respir Res       Date:  2017-05-11

5.  Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma.

Authors:  Xin Huang; Chaobin He; Xin Hua; Anna Kan; Yize Mao; Shuxin Sun; Fangting Duan; Jun Wang; Peng Huang; Shengping Li
Journal:  Clin Transl Med       Date:  2020-06-04

6.  CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis.

Authors:  Dabin Lee; Kyung-Ju Shin; Dong Wook Kim; Kyung-Ae Yoon; Young-Jin Choi; Bom Nae Rin Lee; Je-Yoel Cho
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.